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Infection of H-2b mice with lymphocytic choriomeningitis virus (LCMV) generates three well-characterized H-2Db-restricted
immunodominant epitopes delineated in the NP, GP1, and GP2 proteins. Here we report that the H-2Db-restricted GP1 epitope
GP33-41/43 (KAVYNFATC/GI) located in the signal sequence of LCMV is also the immunodominant epitope recognized by
CTL at the surface of the same infected cells in the context of H-2Kb restriction. The GP1 epitope bound to H-2Db and H-
2Kb molecules with comparable affinities. The respective binding processes involved different sets of peptide anchoring
residues and required dramatically different conformations of the peptide backbone as well as rearrangement of residue
side chains. The 10-mer peptide GP34-43 (AVYNFATCGI) was the optimal H-2Kb-binding sequence and the 8-mer peptide
GP34-41 (AVYNFATC) the minimal sequence for optimal H-2Kb-restricted CTL recognition. Comparison of lytic activities of
primary splenic anti-LCMV CTL from C57BL/6 (Db//Kb/), B10A.[5R] (Db0/Kb/), and B10A.[2R] (Db//Kb0) mice against LCMV-
infected or peptide-coated target cells expressing either one or the two MHC alleles revealed that the H-2Kb-restricted
component of the anti-GP1 CTL response was mounted independently of but as efficiently as its H-2Db counterpart. Analysis
of the immune response against a GP1 variant that escapes CTL recognition showed that the GP1 epitope: (i) was likely
the only immunodominant LCMV epitope in the context of H-2Kb, and (ii) could efficiently evade H-2Db and H-2Kb-restricted
CTL mediated lysis. q 1997 Academic Press
INTRODUCTION Indeed, the presence of multiple MHC binding motifs
found within some viral sequences may allow a few of
Cytotoxic T lymphocytes (CTL) play a crucial role in them to bind to multiple MHC molecules (Bergmann et
eradication of virus by recognizing, at the surface of in- al., 1994; Colbert et al., 1994; Delguercio et al., 1995;
fected cells, viral antigenic peptides presented by major Luescher et al., 1996; Schumacher et al., 1991; Sidney
histocompatibility complex (MHC) class I molecules. The et al., 1995), but led rarely to their recognition by CTL in
CTL response depends on the ability of the viral peptide the context of more than one MHC restriction (Missale
first, to bind to the MHC molecule and second, to trigger et al., 1993; Oldstone et al., 1992; Sheil et al., 1994).
T cell receptor (TCR) activation. Following viral infection, However, occurence of CTL recognition of antigenic pep-
very few peptides (generally one or two) within a viral tides known to bind to different alleles of the same haplo-
protein serve as CTL immunodominant epitopes in the type, has never been observed in vivo in the context of
context of a given MHC class I restriction (Cole et al., more than one allelic restriction (Bergmann et al., 1994;
1994; Kast et al., 1991; Mylin et al., 1995; Oldstone et al., Cole et al., 1994; Matsumura et al., 1992; Schumacher et
1995). Presentation of the peptide and its immunodomi- al., 1991).
nance depend on multiple molecular and cellular mecha- In H-2b mice, acute lymphocytic choriomeningitis virus
nisms (Barber and Parham, 1994). Among them, peptide– (LCMV) infection leads to a CD8/ CTL response (Fung-
MHC interaction is a critical step that requires the pres- Leung et al., 1994; Kyburz et al., 1993; Tishon et al., 1995)
ence of a specific MHC binding motif (Falk et al., 1991) directed predominantly against three H-2Db-restricted
in the peptide sequence and is controled by positive or epitopes located in each of the three viral proteins: the
negative factors at peptides nonanchor positions (Hudri- nucleoprotein NP (Schulz et al., 1989) and glycoproteins
sier et al., 1996; Ruppert et al., 1993). 1 and 2 (GP1 and GP2) (Klavinskis et al., 1992; Oldstone
Usually, a viral antigen contains one single MHC bind- et al., 1988), of which the optimal sequences have been
ing motif and is thus presented to CTL in only one MHC well delineated: NP396–404 (FQPQNGQFI) for NP,
context. However, it is possible to find peptide se- GP33–41/43 (KAVYNFATC/GI) for GP1, and GP276–286
quences that harbor more than one MHC binding motif. (SGVENPGGYCL) for GP2 (Gairin et al., 1995). In addition,
it is known that an LCMV-specific, H-2Kb-restricted CTL
response also exists (Byrne et al., 1984; Klavinskis et al.,1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /33 (0) 561-17-59-94. E-mail: gairin@ipbs.fr. 1992), but its epitope had not been characterized.
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Here we record that the H-2Db-restricted epitope con- tors (1 mM Pefabloc, 0.1 M bestatine, 1 mM EDTA, 0.3
mM aprotinin). Cells were then incubated on ice for 1 hrtained in the signal sequence of LCMV GP1 also har-
bored the H-2Kb binding motif. The GP1 peptide that with 0.1 ml of hybridoma culture supernatant of mouse
monoclonal antibodies Y3 specific for a1 and a2 do-bound to H-2Db also efficiently bound to H-2Kb and com-
prised the dominant CTL response restricted by H-2Kb. mains of H-2Kb (Hammerling et al., 1982) or 28-14-8S
specific for the a3 domain of H-2Db (Ozato et al., 1980),To our knowledge, this is the first evidence that a single
peptide can serve as an immunodominant epitope in the respectively. Negative control was done with medium
alone or irrelevant antibody. After one wash with ice-coldcontext of two MHC alleles copresented at the surface
of the same infected cell to CTL. At the molecular level, BSA-PBS, cells were incubated for 1 hr with a fluorescent
secondary antibody (fluorescein isothiocyanate-conju-the H-2Kb-restricted optimal sequence of the epitope was
delineated using alanine-substitution scanning and N- gated goat anti-mouse IgG, Sigma). After two washes,
cells were fixed in 1% paraformaldehyde in BSA-PBS andand C-terminus truncation analysis. At the cellular level,
the two allelic components of the anti-GP1 CTL response analyzed by fluorescence-activated cell sorter (FacScan,
Becton–Dickinson). Fifty percent stabilizing concentra-were dissected and showed that the viral antigen was
presented to and recognized by CTL in the context of H- tion (SC50) corresponds to the peptide concentration for
which half of the maximum up-regulation is reached.2Db and H-2Kb equivalently. This GP1 epitope was found
to be the only immunodominant LCMV epitope in the
In vitro cytotoxicity assayscontext of H-2Kb.
MC57, T2-Db, and T2-Kb target cells were incubated for
MATERIALS AND METHODS 1 hr at 377 with 51Cr, washed three times with culture
medium, and placed in flat-bottom 96-well plates. LCMV-Cell lines, murine, and viral strains
infected cells or uninfected target cells pulsed with in-
The murine mutant lymphoma cell line RMA-S (H-2b) creasing concentrations (as indicated in figure legends)
was used in stabilization experiments. The murine H-2b of synthetic peptides were subjected to lysis by LCMV-
cell line MC57 and the human cell line T2 transfected specific H-2b-restricted primary splenocytes. Bulk spleno-
with H-2Db (T2-Db) or with H-2Kb (T2-Kb) were used as cytes were used at an E:T ratio of 50 to 1. MC57 cells
target cells in the CTL assays. Cells were grown in RPMI infected 48 hr before the assay with the LCMV Armstrong
1640 (RMA-S and MC57) or IMDM (T2-Kb, T2-Db) con- strain (multiplicity of infection  2) were used as positive
taining 8% bovine serum, L-glutamine, and antibiotics. controls. Uninfected cells in the absence of peptides (50
Geneticin (400 mg/ml) was added to IMDM to maintain ml of culture medium) were used as negative controls.
selection of positively transfected T2-Db and cells T2-Kb. Target and effector cells were incubated at 377 in a final
C57BL/6 (H-2bb) mice were from the Scripps Research volume of 200 ml. After a 5-hr incubation period, fractions
Institute breeding colony. B10.A[2R] (Db, Kk) and B10.A- (100 ml per well) were removed and counted for 51Cr activ-
[5R] (Dd, Kb) mice were obtained from Jackson Labora- ity. The percentage of specific lysis was calculated as
tories. LCMV Armstrong (ARM) wild-type strain clone 53b 100 1 [(cpm, experimental release 0 cpm, spontaneous
was used to infect mice or cells. release)/(cpm, total release 0 cpm, spontaneous re-
lease)]. Total and spontaneous releases were determined
Peptides synthesis and labeling by incubating the labeled cells with 1% Nonidet 40 and
culture medium, respectively. In all experiments, samplesPeptides were synthesized on an automated peptide
were run in triplicate, and means of the values are given.synthetizer (Applied Biosystems 430A) by the solid-phase
method using either t-BOC or FMOC chemistry, purified by
Molecular modelingHPLC on a RP300-C8 reversed-phase column (Brownlee
Lab), and their identity confirmed by fast atom bombard- Molecular modeling of interactions between the LCMV
ment or electro-spray mass spectrum analysis as pre- GP1 peptide and H-2Kb or H-2Db was performed using
viously described (Gairin et al., 1995). Insight II (Biosym Technologies, CA) as described (Hudri-
sier et al., 1996). Starting coordinates were taken fromMHC binding study
the crystal structure of H-2Db in complex with Influenza
NP366–374 (ASNENMETM) (Young et al., 1994) and fromPeptide binding to MHC was studied in stabilization
experiments as previously described (Hudrisier et al., H-2Kb in complex with Vesicular Somatitis Virus (VSV)
NP52–59 (RGYVYQGL) (Zhang et al., 1992). The se-1995). Briefly, RMA-S cells were grown at 257 for 24 hr
before the assay to induce stable H-2Kb or H-2Db mole- quences of the LCMV GP1 peptide selected for modeling
its interaction with H-2Db or H-2Kb were GP33–41 (KAV-cules at the cell surface. Cells (5 1 105 cells/well) were
incubated at 377 in microtiter plates and the stability of YNFATC) and GP34–41 (AVYNFATC) and their structures
were built by coordinates assignment using HOMOLOGYMHC molecules at this temperature was studied as a
function of peptide concentration (1009 to 1004 M ) after (Biosym) from model peptides ASNENMETM and RGY-
VYQGL, respectively. Structures were manually refineda 4-hr incubation period in presence of protease inhibi-
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FIG. 1. Binding of the H-2Db-restricted LCMV and H-2Kb-restricted VSV viral epitopes to H-2Kb and H-2Db. RMA-S cells were incubated with
increasing concentrations (10010 to 1005 M ) of LCMV NP396–404 (FQPQNGQFI), GP33–43 (KAVYNFATCGI), GP276–286 (SGVENPGGYCL), and
VSV NP52–59 (RGYVYQGL) at 377 for a 4-hr incubation period. Peptide-mediated up-regulation of H-2Kb (upper panel) and H-2Db (lower panel) was
assessed by flow cytometry using Y3 (anti-H-2Kb) and 28-14-8S (anti-H-2Db) murine monoclonal primary antibodies followed by anti-mouse FITC-
labeled secondary antibody. Results, expressed as mean fluorescence intensity, are representative among three independent experiments.
before submitted to 100 cycles of energy minimization LCMV GP1 epitope GP33–43 or of the positive control
peptide VSV NP52–59. The two other LCMV epitopesusing DISCOVER (Biosym).
NP396–404 and GP276–286 were totally unable to stabi-
lize H-2Kb even at the highest concentration tested. Stabi-RESULTS
lization of H-2Kb and H-2Db by the GP1 epitope occurred
The H-2Db-restricted LCMV GP1 epitope binds to in the same range of peptide concentrations, reflecting a
H-2Kb with high affinity comparable affinity of the viral peptide for the two alleles.
Similar results were obtained when the 9-mer sequenceThe ability of the three H-2Db-restricted LCMV epitopes
GP33–41 of the epitope was used (not shown).to bind to either H-2Db or H-2Kb was determined in stabili-
zation experiments on the murine mutant cell line RMA-
Binding of the LCMV GP1 epitope to H-2Kb and H-2DbS. The absence of cross-reactivity between the two
involves different sets of residuesmonoclonal antibodies Y3 and 28-14-8S allowed an un-
ambiguous determination of specific peptide-mediated To study the role of each residue of the GP1 epitope
in H-2Kb and H-2Db binding, we analyzed the effect ofupregulation of H-2Kb and H-2Db expression, respectively.
The H-2Kb-restricted epitope VSV NP52-59 (Zhang et al., monoalanine substitution on the MHC binding properties
of the undecameric sequence GP33–43 (KAVYNFATCGI)1992) was used as control peptide. As shown in Fig. 1,
the three H-2Db-restricted LCMV epitopes were able to of the antigen (Gly was used for substitution of Ala34
and Ala39). Figure 2 shows that binding to H-2Kb wasinduce a dose-dependent stabilization of H-2Db mole-
cules at the surface of RMA-S cells, as expected from negatively affected by alanine substitution at four posi-
tions. The drop in affinity observed after substitution ofprevious studies (Gairin et al., 1995; Hudrisier et al., 1996)
while the H-2Kb-restricted epitope VSV NP52– 59 used as Tyr36, Phe38, or C-terminal Ile43 was in accord with the
expected role of these positions as main (Phe38 and Ile43)negative control remained uneffective. In contrast, stabili-
zation of H-2Kb was observed only in the presence of the and auxilliary (Tyr36) anchors to H-2Kb (Falk et al., 1991;
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their splenocytes taken 1 week later and tested in a
classical CTL assay. In the first set of experiments shown
in Fig. 3, we confirmed that, following acute LCMV infec-
tion, an anti-LCMV CTL response was generated in the
context of H-2Kb. LCMV-infected MC57 (Db//Kb/) target
cells were efficiently lysed by bulk splenocytes from
C57BL/6 (Db//Kb/)-, B10A.[5R] (Db0/Kb/)-, and B10A.[2R]
(Db//Kb0)-infected mice showing that the H-2b primary
CTL response mounted against LCMV consisted of two
components: the known H-2Db-restricted response (seen
in B10A.[2R]) and an H-2Kb one (observed in B10A.[5R]).
In a second set of experiments, these splenocytes were
then tested against target cells expressing either only
one (T2-Kb, T2-Db) or both (MC57) of the two alleles and
coated with LCMV GP33-43 or NP396-404 used as a
control. Results are presented in Fig. 4. Data shown in
Figs. 4a, 4c, 4g, and 4i, confirmed the known anti-LCMV,
H-2Db-restricted CTL response against these epitopes
since peptide-coated MC57 and T2-Db target cells were
lysed by CTLs from LCMV-infected C57BL/6 or B10A.[2R]
mice. Data shown in Figs. 4b, 4d, and 4e demonstrated
that the CTL response mounted in vivo in the context of
H-2Kb was indeed directed against the GP1 peptide, giv-
ing similar patterns in the presence (Fig. 4d) or absenceFIG. 2. Effect of mono alanine substitution on the H-2Kb and H-2Db
(Fig. 4e) of the H-2Db-restricted response at the peptidebinding properties of the LCMV GP33-43 epitope. Alanine-substituted
(or Gly-substituted for Ala34 and Ala39) analogues were tested in stabili- concentrations tested. As shown in Figs. 4c and 4i, the
zation assays as described under Materials and Methods and in the H-2Db-restricted response against GP1 was diminished
legend of Fig. 1. Results are expressed as relative affinity for H-2Kb in absence of H-2Kb, reflecting a possible modulation of
(upper panel) or H-2Db (lower panel) of an analogue vs wild-type pep-
the hierachy between the epitopes (Lewicki et al., 1995a;tide by the ratio SC50wt/SC50analogue . SC50wt values for H-2Kb and H-2Db
Oldstone et al., 1995). Finally, as shown unambiguouslywere 214 { 30 nM and 840 { 168 nM, respectively (see Table 1). SC50
is the peptide concentration giving 50% maximal up-regulation. They in Figs. 4f and 4h, peptide-coated target cells expressing
represent one representative experiment among three. only one of the two alleles (H-2Kb in Fig. 4f; H-2Db in Fig.
4h) were not at all recognized nor killed by CTLs re-
stricted by the other allele (H-2Db in Fig. 4f; H-2Kb in Fig.
Jameson and Bevan, 1992; Saito et al., 1993; Shibata et
4h). In control experiments, MC57, T2-Db, or T2-Kb target
al., 1992). The important effect noted after substitution of
cells either uncoated or coated with irrelevant peptide
Asn37 (located between the two anchors Tyr and Phe)
occurred presumably via an indirect conformational ef-
fect. No dramatical change was observed after substitu-
tion at other positions, H-2Kb affinity being slightly modi-
fied (affinity ratio 3), either higher (Lys33, Ala39, Thr40,
Cys41) or lower (Ala34, Val35, Gly42). Concerning H-2Db
binding, four residues were clearly affected by alanine
substitution, demonstrating their role as main (Asn37),
auxilliary (Val35), or potent C-terminal (Cys41, Ile43) H-2Db
anchors, as expected from previous studies (Gairin et
al., 1995). All the other substitutions led to peptides with
comparable (Lys33, Ala34, Phe38, Thr40) or slightly en-
hanced (Tyr36, Ala39, Gly42) H-2Db binding affinity.
The H-2Db-restricted LCMV GP1 peptide is also an
immunodominant H-2Kb-restricted epitope
FIG. 3. H-2Kb and H-2Db-restricted CTL response against LCMV.
C57BL/6 (Db//Kb/), B10A.[5R] (Db0/Kb/) or B10A.[2R] (Db//Kb0) miceHaving established that the H-2Db-restricted LCMV
were infected with LCMV Arm. Seven days latter, their splenocytesGP1 epitope also bound to H-2Kb, we then determined
were tested against 51Cr-labeled MC57 (Db//Kb/) cells infected (black
its ability to generate an anti-LCMV, H-2Kb-restricted CTL bars) or not (white bars) with LCMV Arm in a classical 5-h CTL assay
response. C57BL/6 (Db//Kb/), B10A.[5R] (Db0/Kb/), and (E:T ratio  50:1). Results, expressed as a percentage (%) of specific
lysis, are the mean { SD of two independent experiments.B10A.[2R] (Db//Kb0) mice were infected with LCMV and
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shortening led to the nonapeptide GP33–41 that regained
in MHC affinity (compared to GP33–42) particularly for
H-2Db. Finally, a further deletion resulted in the octamer
GP33–40 that bound only very weakly to either H-2Kb or
H-2Db. Based on these results, N-terminus analysis was
then conducted on the GP33–43 sequence (step 2). Dele-
tion of Lys33 slightly enhanced the H-2Kb binding proper-
ties with a simultaneous and complete drop in H-2Db
affinity, resulting in a peptide with good affinity for H-2Kb
(SC50  164 { 29 nM ) and a remarkable binding selectiv-
ity (H-2Kb vs H-2Db  600). A further shortening (deletion
of Ala34) resulted in a drop in H-2Kb affinity and conse-
quently in selectivity. In a final step, the sequence GP34–
43 was used for a fine delineation of the optimal H-2Kb-
binding sequence of the GP1 peptide. As seen in Table
1 (step 3), none of the truncated analogues of GP34–43
exhibited a better H-2Kb-binding profile at both affinity
and selectivity levels than GP34–43 did.
The 8-mer peptide GP34-41 (AVYNFATC) is the
minimal sequence for optimal H-2Kb-restricted
CTL recognition
C- and N-terminus truncated analogues were then
tested for their ability to sensitize T2-Kb (Db0/Kb/) target
cells to lysis by bulk splenocytes from LCMV-infected
B10A.[5R] (Db0/Kb/) mice. Results are presented in Fig.
5. As shown in the left panel of Fig. 5A, deletion of the
first two residues Ile43 and Gly42 did not result in a drop
in the H-2Kb-restricted CTL sensitization properties, in
contrast to the effect observed on the H-2Kb-binding
properties (see Table 1, step 1). Further, in several inde-FIG. 4. Characterization and dissection of the H-2Kb- and H-2Db-
pendent experiments, the nonamer KAVYNFATC wasrestricted anti-LCMV CTL response. Bulk splenocytes from C57BL/6
(Db//Kb/), B10A.[5R] (Db0/Kb/), or B10A.[2R] (Db//Kb0) mice infected with slightly—but reproductibly—the most effective peptide,
LCMV 7 days before the assay (1st, 2nd, and 3rd columns, respectively) as illustrated in the figure. In contrast, deletion of Cys41
were tested against 51Cr-labeled MC57 (Db//Kb/), T-2Kb (Db0/Kb/) or T- abolished almost completely CTL lysis. N-terminal analy-
2Db (Db//Kb0) target cells (1st, 2nd, and 3rd row, respectively) coated
sis (shown in the right panel of Fig. 5A) revealed thatwith increasing concentrations (1008 to 1005 M ) of LCMV GP33–43
deletion of Lys33 did not bring significant change in CTL(closed symbols), or NP396 – 404 (open symbols) used as control in a
classical 5-hr CTL assay (E:T ratio  50:1). Results, expressed as sensitization, the shorter peptide GP34–43 being barely
percentage (%) of specific lysis are representative of two independent but consistently better than GP33–43 in repeated experi-
experiments. ments. Deletion of Ala34 resulted in a peptide about 2 log
less efficient in inducing CTL killing. As shown in Fig.
5B, fine delineation of the epitope did not lead to a clear-or T2 target cells coated with LCMV peptides were not
cut profile of the GP1 sequence optimal for CTL recogni-lysed (% specific lysis  5%) by splenocytes from LCMV-
tion. The 8-mer AVYNFATC was as efficient as the 10-infected mice (data not shown).
mer AVYNFATCGI to sensitize target cells to CTL killing
The 10-mer GP34-43 peptide (AVYNFATCGI) is the despite a 1 log lower MHC binding affinity (see Table 1,
optimal sequence for selective, high-affinity binding step 3). Finally, the shorter peptide, the 7-mer GP34-40
to H-2Kb (AVYNFAT) still induced a good killing despite its very
weak binding affinity for H-2Kb (see Table 1, step 3), inTo determine the H-2Kb-restricted optimal sequence of
the same concentration range than that of the 9-mer
the GP1 peptide in terms of affinity and selectivity (Kb/Db),
GP34-42 (AVYNFATCG).
C- and N-terminus truncated analogues of GP33–43 were
The central core sequence GP35–38 (VYNF) oftested for their respectives H-2Kb and H-2Db binding prop-
the GP1 epitope adopts dramatically differenterties as described above (see stabilization experiments
conformations in the context of H-2Kb or H-2Dbon RMA-S cells). As shown in Table 1 (step 1), GP33–43
complexesdisplayed a 4-times higher affinity for H-2Kb than for H-
2Db. Deletion of the C-terminal residue Ile43 resulted in a To better understand at both the molecular and atomic
levels how the same peptide can bind to two differentdramatic drop in affinity for both alleles. An additional
AID VY 8627 / 6a3b$$$403 07-07-97 09:05:16 viral AP: VY
67DUAL ALLELIC PRESENTATION OF LCMV GP1 EPITOPE
TABLE 1
H-2Kb and H-2Db Binding Affinities of N- and C-Terminus Truncated Analogues of the LCMV GP1 Epitope
Binding affinity
H-2Kb H-2Db Selectivity
Peptide (SC50 , nM) (SC50 , nM) (H-2Kb vs H-2Db)
Step 1: C-terminus analysis
GP 33-43 KAVYNFATCGI 214 { 30 840 { 168 3.9
GP 33-42 KAVYNFATCG 77 750 { 7200 19 200 { 2 750 2.5
GP 33-41 KAVYNFATC 1 314 { 179 459 { 84 0.3
GP 33-40 KAVYNFAT 28 860 { 1 450 64 000 { 8 370 2.2
Step 2: N-terminus analysis
GP 33-43 KAVYNFATCGI 214 { 30 840 { 168 3.9
GP 34-43 AVYNFATCGI 164 { 29 100 000 600
GP 35-43 VYNFATCGI 4 240 { 496 100 000 23
Step 3: fine delineation
GP 34-43 AVYNFATCGI 164 { 29 100 000 600
GP 34-42 AVYNFATCG 3 600 { 248 100 000 28
GP 34-41 AVYNFATC 1 417 { 122 100 000 71
GP 34-40 AVYNFAT 46 500 { 2 180 100 000 2
Note. RMA-S cells were incubated with increasing concentrations (1009 to 1004 M) of LCMV GP 33-43 or its N- and C-terminus truncated analogues
for 4 hr at 377. Peptide-mediated up-regulation of H-2Kb and H-2Db expression was assessed by flow cytometry as described in the legend of Fig.
1 and under Materials and Methods. Values are the mean { SEM of at least three independent experiments.
alleles, the structure of GP1 in complex with H-2Kb or H- text of H-2Kb and H-2Db (Young et al., 1994; Zhang et al.,
1992). Both models are presented in Fig. 6. The modeled2Db was analyzed by molecular modeling. Starting from
crystallographic coordinates of VSV8-H-2Kb (Zhang et al., structure of GP1 in complex with H-2Kb (Fig. 6A) showed
that side chains of residues Tyr36, Phe38, and Cys41 inter-1992) and FLU-H-2Db (Young et al., 1994) complexes,
we inserted the GP1 epitope in the respective binding acted strongly with the MHC and that those of Asn37,
Ala39, Thr40, and, at a lower degree, Ala34 were accessiblegrooves of its two restriction elements. The sequences
AVYNFATC and KAVYNFATC were chosen for molecular to the TCR. In contrast, when GP1 was modeled in inter-
action with H-2Db (Fig. 6B), a dramatic conformationalmodeling of GP1 binding to H-2Kb and H-2Db, respec-
tively, given their optimal recognition by CTLs and their change was observed at the level of the central core
motif VYNF of the peptide sequence. In the H-2Db con-identical length with peptides cocrystallized in the con-
FIG. 5. Fine delineation of the H-2Kb-restricted LCMV GP1 epitope sequence. C- and N-terminus-truncated analogues of GP33–43 (A) and C-
terminus-truncated analogues of GP34–43 (B) were tested for their ability to sensitize 51Cr-labeled T-2Kb target cells to lysis by bulk splenocytes
from LCMV-infected B10A.[5R] mice in a classical 5-hr CTL assay. Peptide concentrations varied from 10011 to 1006 M. E:T ratio was 50:1. Results,
expressed as percentage of specific lysis are representative of two independent experiments.
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FIG. 6. Computerized molecular model of the LCMV GP1 epitope in complex with H-2Kb (A) or H-2Db (B). Molecular modeling was performed
using Insight II (Biosym Technologies, CA) starting from the coordinates of H-2Kb in complex with Vesicular Somatitis Virus (VSV) NP52–59
(RGYVYQGL) (Zhang et al., 1992) and of H-2Db in complex with Influenza NP366–374 (ASNENMETM) (Young et al., 1992). The LCMV GP33–41 and
GP34–41 structures were built by coordinates assignment from model peptides using HOMOLOGY (Biosym). A side view is shown. Schemes
assigning the role of each residue of the epitope in either MHC binding or TCR recognition are represented in the bottom of the panels.
text, the side chains of Val35 and Asn37 were now oriented TCR contact residue that abolishes CTL recognition, an
hypothesis in accord with previous studies (Lewicki etinside the MHC molecule together with Cys41 while those
of Tyr36 and Phe38 were directed toward the TCR, together al., 1995; Oldstone et al., 1995) and illustrated in the
molecular model (see above). In contrast, antigen pre-with Lys33, Thr40, and, to a lesser extent, Ala39.
sentation by H-2Kb was dramatically affected by the mu-
tation since the mutated peptide showed a 3 log de-The LCMV GP1 variant (Phe38 r Leu38) escapes CTL
crease in H-2Kb binding affinity compared to the nonmu-recognition by two independent mechanisms
tated antigen. In this case, the mutation affects the main
The single mutation Phe38 r Leu38 in the LCMV GP1 peptide anchor residue to the MHC (Falk et al., 1991;
protein sequence allows the virus to escape the H-2b Shibata et al., 1992), in accord with the binding data and
restricted, GP1-specific CTL response (Lewicki et al., the molecular model (see sections above), and conse-
1995; Oldstone et al., 1995; and Fig. 7A). To dissect the quently abrogates its presentation to CTL.
molecular mechanisms by which escape may occur in
the context of H-2Db and H-2Kb, we analyzed the ability DISCUSSION
of the variant sequence to be presented by each of the
two alleles. For that, the MHC binding properties of the In this study we have characterized the H-2Kb-re-
stricted immunodominant epitope of LCMV. It shares themutated peptide [Leu38]-GP33–41 (KAVYNLATC) were
measured as described above and compared to those sequence of the H-2Db-restricted GP1 epitope in the sig-
nal peptide of the viral GP protein, and the anti-GP1of the nonmutated sequence GP33–41 (KAVYNFATC). As
shown in Fig. 7B, the mutation Phe38 r Leu38 did not T cell response that followed acute LCMV infection is
mounted separately and efficiently in the two contexts.affect presentation of the viral antigen by H-2Db since
both peptides bound to H-2Db with comparable affinities. Our data show for the first time that a unique viral peptide
can be efficiently presented in vivo at the surface of theIn this context, escape occurs via alteration of the crucial
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FIG. 7. The GP1 variant (Phe38 r Leu38) escapes CTL recognition by two different mechanisms. In A, primary bulk splenocytes from C57BL/6
mice infected with LCMV wt (Phe38, black bar) or GP variant (Leu38, white bar) were tested for their ability to lyse H-2b MC57 target cells infected
with vaccinia virus recombinants expressing LCMV GP1 (Oldstone et al., 1995) in a classical 5-hr CTL assay (E:T ratio  50:1). In B, the H-2Db or
H-2Kb binding properties of the LCMV wt GP1 peptide sequence GP33–41 (KAVYNFATC, closed symbols) and its CTL escape variant mutated form
[Leu38]-GP33–41 (KAVYNLATC, open symbols) were evaluated in stabilization assays as described under Materials and Methods and in the legend
of Fig. 1.
same infected cell by two different MHC alleles and of H-2Db restriction, and conversely. Thus, the H-2Kb- and
H-2Db-restricted CTL responses raised against the GP1can induce an immunodominant CTL response in both
instances. Despite reports of the presence of multiple epitope in acutely infected mice are mounted separately,
are efficient in the two contexts, and involve independentMHC binding motifs in a single sequence, only a few
antigenic determinants are presented in vivo by MHC sets of MHC-restricted CTL. One can consider that the
GP1 epitope behaves as two structurally distinct antigensmolecules of different haplotypes (Missale et al., 1993;
Oldstone et al., 1992; Shirai et al., 1992). However, CTL in the two contexts. Indeed, TCR recognition of a viral
antigen occurs not only via discrete contacts but alsorecognition of a viral peptide copresented by two differ-
ent MHC alleles of the same haplotype has not been via an antigenic molecular surface of the peptide/MHC
complex (Garboczi et al., 1996; Garcia et al., 1996; Quara-reported to date. For example, the Sendai virus peptide
SEV-9 (NP324– 332) binds to the two H-2b alleles H-2Db tino et al., 1995). It is likely that the antigenic surfaces
of the GP1/H-2Kb and GP1/H-2Db complexes in contactand H-2Kb (Deres et al., 1992; Schumacher et al., 1991),
can generate an extremely diverse CTL response in vivo with the TCR markedly differ. Interestingly, 3 of 8 polymor-
phic residues of the MHC a1 and a2 domains which are(Cole et al., 1994), but is only recognized by CTL in the
context of H-2Kb (Cole et al., 1994; Kast et al., 1991, accessible to the TCR and differ in H-2Db and H-2Kb
molecules have been described as TCR contacts (Ajitku-Schumacher et al., 1991). Interestingly, in vitro studies
have shown that a single peptide can indeed be pre- mar et al., 1988; Sun et al., 1995). In addition, the possibil-
ity that most of the residues of the GP33–41 sequencesented to CTL by both H-2Db and H-2Kb molecules (Sheil
et al., 1994). (C-terminal anchor excepted) can serve as TCR contacts
in one MHC context or the other, adds to the variabilityDo H-2Kb and H-2Db separately restrict the LCMV GP1
epitope? Since MHC molecules directly influence antigen of the antigenic surface and potentially increases the
diversity of the T cell repertoire.processing (Falk et al., 1990; Kozlowski et al., 1993; Ma-
larkannan et al., 1995; Ojcius et al., 1994) and conse- Is GP1 the unique H-2Kb-restricted immunodominant
epitope of LCMV? Computer scanning of the LCMV pro-quently the CTL response, an important point to address
was the independence (vs H-2Db) and the efficiency of tein sequences revealed that 18 other peptides harbored
the H-2Kb binding motif (Hudrisier and Gairin, unpub-the anti-GP1, H-2Kb-restricted CTL response. Dissection
of the H-2Kb-restricted GP1-specific T-cell response did lished observation) and might represent potential H-2Kb-
restricted epitopes. However, the observations that muta-not reveal significantly different CTL activity patterns in
the presence or absence of H-2Db expression (see Figs. tions within the known LCMV H-2b-restricted epitope se-
quences abolished CTL recognition and did not generate4a, 4b, 4d, and 4e). Furthermore, the phenomenon of H-
2 restriction (also illustrated in Figs. 4f and 4h) showed an efficient CTL response against another antigen (Lew-
icki et al., 1995, 1995a; Oldstone et al., 1995; and Fig.unambiguously that anti-GP1 H-2Kb-restricted CTL did
not recognize the viral antigen presented in the context 7A) strongly suggested that none of these 18 peptides
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represented an immunodominant H-2Kb-restricted epi- H-2Kb) (see Fig. 7B) and the other that very likely affects
TCR recognition (in the context of H-2Db). This resulttope, favoring the hypothesis that GP34–41 is the unique
immunodominant LCMV epitope in this context. was predictable from molecular modeling studies (see
Fig. 6).The finding that the GP1 epitope induces an efficient
CTL response in both H-2Db and H-2Kb contexts has By what mechanism does the GP1 epitope bind to H-
2Db and H-2Kb? A peptide can bind to multiple MHCimportant consequence in the understanding of the cellu-
lar immune response to LCMV infection. First, although molecules due to overlapping MHC motifs (Colbert et al.,
1994; Delguercio et al., 1995; Fruci et al., 1994; Kikuchithe GP1 peptide does not match perfectly the MHC bind-
ing motif (Falk et al., 1991; Gairin et al., 1995) and exhibits et al., 1996; Luescher et al., 1996; Sidney et al., 1995;
Tanigaki et al., 1994) or by different mechanisms (Deresthe lowest MHC binding affinity among the known LCMV
(Gairin et al., 1995) and other H-2Db viral epitopes (Hudri- et al., 1992; Matsumura et al., 1992; Schumacher et al.,
1991). The binding of the LCMV GP1 epitope to H-2Dbsier et al., 1996), the increased repertoire diversity due
to its dual allelic presentation may allow the GP1 epitope and H-2Kb is due to the adjacent location of the H-2Db
and H-2Kb main anchors (Asn37 and Phe38, respectively)to generate an efficient primary and/or secondary CTL
response in H-2b mice following acute LCMV infection in the peptide sequence, a structural feature similarly
observed for the ovalbumin epitope OVA256-264 (ESIINF-(Whitton et al., 1988) or vaccination with the peptide itself
(Aichele et al., 1994, 1995; Kyburz et al., 1993) or mini- EKL) (Matsumura et al., 1992). Further, the molecular
models (see Fig. 6) illustrated how the core of the CTLgenes in vaccinia virus vectors (Klavinskis et al., 1992).
Second, the immunodominance and the efficiency of the epitope (recognition peptide) adopted markedly different
conformations in the two MHC grooves, indicating thatH-2Kb-restricted component of the anti-GP1 CTL re-
sponse may explain, at least in part, why acute LCMV flexibility of the peptide backbone and adaptability of its
side chains to a given binding groove are also importantinfection is still controled after altering or blocking the
H-2Db-restricted component. This is well shown in RIP- structural factors necessary for multiple MHC binding.
The optimal H-2Kb binding sequence of the LCMV GP1LCMV NP transgenic mice that either coexpress adenovi-
ral E3 gene (that prevents trafficking of H-2Db but not H- epitope (the decameric peptide GP34–43, AVYNFATCGI)
is in accord with the expected anchor residues Tyr and2Kb) in b-cells (von Herrath et al., 1997) or are treated with
an H-2Db-blocking peptide (von Herrath et al., 1997a). In Phe at positions 3 and 5, respectively (Rammensee et
al., 1995) but does not fit the canonical length of 8 resi-these mice, virus is still cleared following LCMV chal-
lenge, presumably by the H-2Kb component of the anti- dues which is the most commonly observed for H-2Kb-
restricted antigens (Matsumura et al., 1992; RammenseeCTL response. Interestingly, the observation that these
mice do not develop diabetes following LCMV challenge et al., 1995). In fact, it has been shown that the preferred
size of H-2Kb-restricted peptides is sequence-dependentvery likely reflects the absence of H-2Kb-restricted anti-
NP CTL response. (Deres et al., 1992) and peptides longer than 8 a.a. have
been characterized that bound to H-2Kb (Joyce et al.,Dual MHC allelic presentation of the same viral anti-
gen to CTL also has a profound incidence on host – virus 1994; Schumacher et al., 1991). The presence at the C-
terminus of a residue not able to serve as MHC anchorinteraction and CTL escape strategies. Many pathogens
escape CTL recognition by single mutation of an epitope (Gly42 for instance) resulted in decreased binding proper-
ties, an effect more pronounced on H-2Db, as expectedresidue (Franco et al., 1995). The relevance in vivo of
antigenic variants for escape strategies is still controver- from previous studies (Gairin et al., 1995; Matsumura et
al., 1992). Interestingly, a very good selectivity for H-2Kbsial, and whether or not mutations in the sequence of an
antigen presented by multiple MHC give an advantage to was confered to the epitope by removal of the N-terminal
Lys33 residue whereas, in contrast, only a very weak (ifthe host to avoid viral escape strategies (Moskophidis
and Zinkernagel, 1995; Sidney et al., 1995; and our study) any) H-2Db selectivity could be obtained (all the GP1
sequences tested bound almost equally well to H-2Dbremains to be determined. Natural LCMV GP1 variants
that escape CTL recognition are known (Lewicki et al., and H-2Kb). This latter data helps explain previous obser-
vations showing that the H-2Db binding properties of the1995; Moskophidis and Zinkernagel, 1995; Oldstone et
al., 1995; Pircher et al., 1990). The fact that polyclonal GP1 epitope were affected by H-2Kb expression (Gairin
et al., 1995). In terms of CTL recognition, the octamericpopulations of H-2b CTL (bulk splenocytes from C57BL/
6 mice) were used in these studies strongly suggests sequence GP34–41 (AVYNFATC) optimally sensitized
target cells to H-2Kb-restricted CTL lysis, despite notthat these variants escape CTL lysis in both H-2Kb and
H-2Db contexts. We have reported previously that H-2Db- showing the highest H-2Kb binding affinity. This lack of
correlation between MHC binding and CTL recognitionrestricted CTL pressure places one of these mutations
(Phe38 r Leu38) at a key residue of the GP1 sequence reflected that the C-terminal dipeptide Gly42-Ile43, al-
though enhancing the MHC binding properties, was use-(Lewicki et al., 1995, 1995a). Our present data support
the hypothesis that, in this variant, the viral strategy to less for CTL recognition in both contexts (H-2Db and
H-2Kb). This confirmed that non-preferred MHC bindingescape CTL lysis combines two different mechanisms:
one that hampers MHC presentation (in the context of peptides can be efficiently presented to CTL (Chen et
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Naturally processed peptides longer than nine amino acid residuesal., 1994). These findings further raise the questions of
bind to the class I MHC molecule HLA-A2.1 with high affinity and inhow the GP1 epitope is processed from the signal se-
different conformations. J. Immunol. 152, 2874–2881.
quence of the virus and which exact sequence(s) is(are) Colbert, R. A., Rowlandjones, S. L., Mcmichael, A. J., and Frelinger, J. A.
naturally presented by H-2Db and H-2Kb to CTL at the (1994). Differences in peptide presentation between B27 subtypes:
surface of LCMV-infected H-2b cells. Their identification, The importance of the P1 side chain in maintaining high affinity
peptide binding to B*2703. Immunity 1, 121–130.based on the characterization of peptides eluted from
Cole, G. A., Hogg, T. L., and Woodland, D. L. (1994). The MHC class I-MHC molecules, is currently under investigation in our
restricted T cell response to Sendai virus infection in C57BL/6 mice:laboratories.
a single immunodominant epitope elicits an extremely diverse reper-
In summary, the work presented in this study open toire of T cells. Int. Immunol. 6, 1767–1775.
up issues on the incidence and role of the dual allelic Delguercio, M. F., Sidney, J., Hermanson, G., Perez, C., Grey, H. M.,
Kubo, R. T., and Sette, A. (1995). Binding of a peptide antigen topresentation of CTL epitope. The subject has been de-
multiple HLA alleles allows definition of an A2-like supertype. J. Im-fined in context of LCMV Arm GP1 epitope and more
munol. 154, 685–693.particularly of its H-2Kb-restricted component on the
Deres, K., Schumacher, T. N. M., Wiesmuller, K. H., Stevanovic, S.,pathogenesis of LCMV infection. It will be interesting to Greiner, G., Jung, G., and Ploegh, H. L. (1992). Preferred size of pep-
follow the pathological mechanisms of viral persistence tides that bind to H-2Kb is sequence dependent. Eur. J. Immunol. 22,
and of CTL escape strategies in H-2Db0/0 or H-2Kb0/0 1603–1608.
Falk, K., Rotzschke, O., and Rammensee, H. G. (1990). Cellular peptideknock-out transgenic H-2b mice. It is also noteworthy that
composition governed by major histocompatibility complex class Ithe H-2Db-, H-2Kb-restricted LCMV GP1 epitope contains
molecules. Nature 348, 248–251.within its sequence the H-2Kd binding motif and could
Falk, K., Rotzschke, O., Stevanovic, S., Jung, G., and Rammensee, H. G.
represent a subdominant H-2d-restricted epitope (van der (1991). Allele-specific motifs revealed by sequencing of self-peptides
Most et al., 1996). In toto these observations provide eluted from MHC molecules. Nature 351, 290–296.
support for the concept that CTL epitopes may form clus- Franco, A., Ferrari, C., Sette, A., and Chisari, F. V. (1995). Viral mutations,
TCR antagonism and escape from the immune response. Curr. Opin.ters (Tussey et al., 1995; Wilson et al., 1996) within a viral
Immunol. 7, 524–531.protein sequence. In terms of therapeutic application,
Fruci, D., Greco, G., Vigneti, E., Tanigaki, N., Butler, R. H., and Tosi, R.such single, minimal viral sequences that encompass
(1994). The peptide-binding specificity of HLA-B27 subtype (B*2705)
overlapping CTL epitopes represent candidates of prime analyzed by the use of polyalanine model peptides. Hum. Immunol.
interest for the design and the development of anti-viral, 41, 34–38.
peptide- or DNA-based vaccination strategies. Fung-Leung, W. P., Kundig, T. M., Ngo, K., Panakos, J., De Sousa-Hitzler,
J., Wang, E., Ohashi, P. S., Mak, T. W., and Lau, C. Y. (1994). Reduced
thymic maturation but normal effector function of CD8/ T cells in
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